Glycopyrrolate Injection, Solution
Product Images NDC 0404-9775

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 0404-9775). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Henry Schein, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula1.jpg (Formula1)

Chemical structure of glycopyrrolate showing the molecular formula C19H28BrNO3 and molecular weight 398.33 displayed below the diagram.*

FDA Label Image

Image1.jpg (Image1)

A data table comparing pharmacokinetic parameters of glycopyrrolate injection for two groups: 6 mcg/kg intravenous (IV) and 8 mcg/kg intramuscular (IM). Parameters include half-life (t1/2), steady-state volume of distribution (Vss), clearance (CL), time to maximum concentration (Tmax), maximum concentration (Cmax), and area under the curve (AUC). Values are reported with means and standard deviations where available.*

FDA Label Image

Image2.jpg (Image2)

A data table presenting Glycopyrrolate Injection, USP, with various NDC codes, strengths, vial types, and package factors including single-dose and multi-dose vials in different concentrations packaged in cartons of 10 or 25 vials.*

FDA Label Image

Label1.jpg (Label1)

Glycopyrrolate 0.2 mg/mL Injection, USP single-dose vial label intended for intramuscular or intravenous use. The label states it is sterile, nonpyrogenic, contains benzyl alcohol, and is not for use in newborns. Packaged by Henry Schein, Inc., with lot, expiration, and NDC 0404-9775-01 barcode shown. Storage instructions and warnings are included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.